• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    5/31/23 1:01:38 PM ET
    $AAP
    $AI
    $AMBA
    $ARDS
    Auto & Home Supply Stores
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology
    Get the next $AAP alert in real time by email

    Gainers

    • Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of AR-301 and the clinical study design.
    • Bluejay Diagnostics, Inc. (NASDAQ:BJDX) gained 67% to $0.3225.
    • VIQ Solutions Inc. (NASDAQ:VQS) shares jumped 49.1% to $0.3474.
    • Marker Therapeutics, Inc. (NASDAQ:MRKR) climbed 31% to $1.73 after the company reported pre-clinical data of its MT-601 multiTAA-specific T cell product candidate MT-601 in lymphoma cells.
    • Tenax Therapeutics, Inc. (NASDAQ:TENX) rose 30% to $0.4151. Tenax Therapeutics achieved major milestone as USPTO granted notice of allowance for U.S. patent application covering use of oral levosimendan in pulmonary hypertension with heart failure with preserved ejection fraction.
    • VistaGen Therapeutics, Inc. (NASDAQ:VTGN) shares gained 19.4% to $0.1599 after the company announced it will present fasedienol safety and exploratory efficacy data from its Phase 3 open-label social anxiety disorder study at the ASCP 2023 Annual Meeting.
    • LL Flooring Holdings, Inc. (NYSE:LL) shares climbed 18.8% to $4.92. LL Flooring confirmed the receipt of $5.76 per share unsolicited, non-binding proposal from Cabinets To Go, a subsidiary of F9 Brands.
    • CXApp Inc. (NASDAQ:CXAI) gained 17.5% to $13.06.
    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) climbed 17.4% to $0.6574. Kaival Brands acquired Extensive vaporizer and inhalation patent portfolio to diversify product offerings and create new revenue opportunities.
    • Invivyd, Inc. (NASDAQ:IVVD) gained 16% to $1.78.
    • WANG & LEE GROUP, Inc. (NASDAQ:WLGS) rose 14% to $1.5850 after declining around 5% on Tuesday.
    • Loop Media, Inc. (NYSE:LPTV) surged 13.3% to $3.67.
    • Exela Technologies, Inc. (NASDAQ:XELA) gained 12.7% to $5.33.
    • Nano-X Imaging Ltd. (NASDAQ:NNOX) climbed 12.7% to $19.23.
    • Chindata Group Holdings Limited (NASDAQ:CD) gained 11.1% to $5.59 after reporting first-quarter results.
    • Lyell Immunopharma, Inc. (NASDAQ:LYEL) shares rose 10.8% to $3.0595.
    • Palomar Holdings, Inc. (NASDAQ:PLMR) gained 10.6% to $52.30 as the company announced successful completion of June 1 reinsurance renewal and raised full year 2023 adjusted net income guidance.
    • Centerra Gold Inc. (NYSE:CGAU) surged 10.3% to $6.03.
    • SoFi Technologies, Inc. (NASDAQ:SOFI) gained 10% to $6.64 following a tentative debt limit agreement, which would reinstate student loan payments.
    • Intel Corporation (NASDAQ:INTC) surged 6% to $31.76 amid the company's presentation at TD Cowen's 51st Annual Technology, Media & Telecom Conference.

    Losers

    • QualTek Services Inc (NASDAQ:QTEK) fell 41.3% to $ 0.0880 after the company received Nasdaq delisting notice.
    • Belite Bio, Inc (NASDAQ:BLTE) shares dipped 33.2% to $15.70 after the company reported pricing of a $30 million underwritten public offering of ADSs and warrants.
    • Advance Auto Parts, Inc. (NYSE:AAP) fell 33.2% to $74.98 after the company reported worse-than-expected first-quarter financial results and cut FY23 guidance below estimates.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares dropped 39.5% to $0.0821. Biodexa Pharmaceuticals recently reported closing of $3.32 million registered direct offering.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell 37% to $0.2138. Panbela announced a 1-for-30 reverse stock split effective June 1, 2023.
    • Golden Minerals Company (NYSE:AUMN) dropped 26.9% to $0.1155. Golden Minerals Company company announced a 1-for-25 reverse stock split.
    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) fell 22.1% to $0.95.
    • Wejo Group Ltd (NASDAQ:WEJO) fell 18.2% to $0.1012. Wejo Group shares dipped 57% on Tuesday after the company said it is evaluating whether to file ancillary insolvency proceedings for the company and other units in other jurisdictions, including the US.
    • Lantronix, Inc. (NASDAQ:LTRX) dropped 18.1% to $4.30. Lantronix said Paul Pickle will be resigning from his role as President and CEO.
    • Wearable Devices Ltd. (NASDAQ:WLDS) fell 17.1% to $1.5250. Wearable Devices last week announced its Mudra Band for Apple Watch is available for preorder.
    • EpicQuest Education Group International Limited (NASDAQ:EEIQ) dropped 17% to $2.05.
    • Ambarella Inc (NASDAQ:AMBA) fell 15.9% to $68.98 after the company issued a weak second-quarter forecast.
    • Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH) fell 15.3% to $4.65 as the company posted a wider-than-expected loss for its first quarter and issued weak forecast for the current quarter.
    • Hovnanian Enterprises, Inc. (NYSE:HOV) fell 14.5% to $80.21 after reporting second-quarter results. Hovnanian Enterprises also said it sees FY23 revenue of $2.5 billion to $2.65 billion and FY23 EPS of $17 to $20.
    • GT Biopharma, Inc. (NASDAQ:GTBP) dropped 13.7% to $0.2173.
    • SEALSQ Corp (NASDAQ:LAES) fell 13.2% to $11.80.
    • TOP Financial Group Limited (NYSE:TOP) dropped 11.8% to $9.14.
    • U-Haul Holding Company (NYSE:UHAL) fell 11.6% to $55.70 after the company reported worse-than-expected Q1 results.
    • Capri Holdings Limited (NYSE:CPRI) dropped 10.8% to $35.28 following fourth-quarter results. Capri sees first-quarter revenue of ~$1.2 billion against the Street view of $1.3 billion and sees EPS of $0.70.
    • C3.ai, Inc. (NYSE:AI) fell 10.5% to $39.35 mid profit taking following a rally in AI stocks.
    • Horizon Technology Finance Corporation (NASDAQ:HRZN) shares fell 10.4% to $11.89. Horizon Technology Finance priced an underwritten public offering of 3,250,000 shares at a price of $12.50 per share for total gross proceeds of around $40,625000.
    • Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) shares dropped 10.1% to $0.6898.
    • Carvana Co. (NYSE:CVNA) dropped 9.7% to $12.39. JMP Securities reiterated Carvana with a Market Outperform and maintained a $15 price target.
    • UTime Ltd (NASDAQ:UTME) fell 9.4% to $1.3597 after jumping 30% on Tuesday.
    • Chico's FAS, Inc. (NYSE:CHS) dropped 8.7% to $4.71. Telsey Advisory Group reiterated Chico's FAS with a Market Perform and maintained a $6 price target.
    • Donaldson Company, Inc. (NYSE:DCI) fell 8.1% to $58.92. Donaldson reported a third-quarter FY23 sales increase of 2.6% Y/Y to $875.7 million beating the consensus of $868.4 million. The company now expects FY23 adjusted EPS to be $3.00-$3.06 (vs $2.99-$3.07 previously) compared to the consensus of $3.04.
    • Hewlett Packard Enterprise Company (NYSE:HPE) shares declined 6.4% to $14.53 after reporting downbeat second-quarter sales.
    • Frontline Plc (NYSE:FRO) shares declined 4.9% to $14.30 following first-quarter results.
    • HP Inc (NYSE:HPQ) shares dropped 3.2% to $29.93. HP reported better-than-expected earnings for its second quarter, while sales missed expectations.

     

    Now Read This: Bitcoin Drops But Remains Above This Key Level; Optimism, Conflux Among Top Losers

    Get the next $AAP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAP
    $AI
    $AMBA
    $ARDS

    CompanyDatePrice TargetRatingAnalyst
    SoFi Technologies Inc.
    $SOFI
    3/19/2026$19.00Equal Weight
    Wells Fargo
    Tenax Therapeutics Inc.
    $TENX
    3/17/2026$35.00Overweight
    Cantor Fitzgerald
    Lyell Immunopharma Inc.
    $LYEL
    3/9/2026$34.00Mkt Outperform
    Citizens
    Horizon Technology Finance Corporation
    $HRZN
    3/5/2026$5.00Underperform → Mkt Perform
    Keefe Bruyette
    C3.ai Inc.
    $AI
    2/26/2026Mkt Outperform → Mkt Perform
    Citizens
    Intel Corporation
    $INTC
    2/13/2026$45.00Neutral
    DA Davidson
    Palomar Holdings Inc.
    $PLMR
    2/9/2026$150.00Outperform
    Evercore ISI
    SoFi Technologies Inc.
    $SOFI
    2/9/2026$30.00Mkt Perform → Mkt Outperform
    Citizens
    More analyst ratings

    $AAP
    $AI
    $AMBA
    $ARDS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Wu Zhenyu

    3 - EpicQuest Education Group International Ltd (0001781397) (Issuer)

    3/18/26 8:26:42 PM ET
    $EEIQ
    Other Consumer Services
    Real Estate

    SEC Form 3 filed by new insider Zhang Jianbo

    3 - EpicQuest Education Group International Ltd (0001781397) (Issuer)

    3/18/26 8:23:59 PM ET
    $EEIQ
    Other Consumer Services
    Real Estate

    SEC Form 4 filed by Noto Anthony

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/18/26 8:16:42 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $AAP
    $AI
    $AMBA
    $ARDS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lantronix and Unusual Machines Partner to Deliver NDAA-Compliant AI-Autonomous Drone Components for U.S. Defense Programs

    IRVINE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ:LTRX), a global provider of Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned systems, critical infrastructure, and resilient enterprise networks, and Unusual Machines, Inc. (NYSE:UMAC), a leading provider of NDAA-compliant drone components, today announced a strategic collaboration to develop next-generation autonomous drone components integrating edge AI compute with mission-critical flight control systems. The collaboration aligns with accelerating U.S. defense investment in manufacturing autonomous systems at scale. The U.S. Department of War's Drone Dominance Program, a $1.1 billion, multi

    3/19/26 7:00:00 AM ET
    $LTRX
    $UMAC
    Computer Communications Equipment
    Telecommunications
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Horizon Technology Finance and CR Financial Holdings Form New $100 Million Joint Venture

    Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon"), an affiliate of Monroe Capital, announced today the formation of a new joint venture with CR Financial Holdings, Inc. ("CRFH"), the holding company for Roth Capital Partners, LLC ("Roth"). The joint venture will provide growth capital financing solutions to small- and micro-cap public companies based primarily in the U.S. Horizon and CRFH will make initial capital commitments totaling $100 million. The joint venture intends to leverage its initial capital by entering into warehouse credit facilities from time to time. Governance and investment decisions will be made by a four-person board and a four-person investment commit

    3/19/26 6:00:00 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

    Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses Research published in Nature Medicine highlighted promising results of multi-antigen targeted T cells in pancreatic cancer Strengthened manufacturing capabilities through collaboration with Cellipont Bioservices and expanded Board of Directors with appointment of Kathryn Penkus Corzo HOUSTON, March 18, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematological malignancies and solid tumors, today a

    3/18/26 5:31:30 PM ET
    $MRKR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAP
    $AI
    $AMBA
    $ARDS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Noto Anthony bought $500,516 worth of shares (28,900 units at $17.32), increasing direct ownership by 0.25% to 11,704,352 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    3/17/26 4:05:47 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Chairman & CEO Idol John D bought $988,900 worth of Ordinary shares (55,000 units at $17.98), increasing direct ownership by 2% to 2,257,645 units (SEC Form 4)

    4 - Capri Holdings Ltd (0001530721) (Issuer)

    3/11/26 8:38:42 PM ET
    $CPRI
    Apparel
    Consumer Discretionary

    Large owner Arch Venture Partners Ix, Llc bought $12,499,985 worth of shares (488,090 units at $25.61) (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    3/9/26 4:36:20 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAP
    $AI
    $AMBA
    $ARDS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on SoFi Technologies with a new price target

    Wells Fargo initiated coverage of SoFi Technologies with a rating of Equal Weight and set a new price target of $19.00

    3/19/26 8:27:12 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    Cantor Fitzgerald initiated coverage on Tenax Therapeutics with a new price target

    Cantor Fitzgerald initiated coverage of Tenax Therapeutics with a rating of Overweight and set a new price target of $35.00

    3/17/26 8:15:05 AM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Citizens initiated coverage on Lyell Immunopharma with a new price target

    Citizens initiated coverage of Lyell Immunopharma with a rating of Mkt Outperform and set a new price target of $34.00

    3/9/26 9:07:38 AM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAP
    $AI
    $AMBA
    $ARDS
    SEC Filings

    View All

    Horizon Technology Finance Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Horizon Technology Finance Corp (0001487428) (Filer)

    3/19/26 7:33:32 AM ET
    $HRZN
    Finance: Consumer Services
    Finance

    SEC Form 10-K filed by Marker Therapeutics Inc.

    10-K - Marker Therapeutics, Inc. (0001094038) (Filer)

    3/18/26 5:26:35 PM ET
    $MRKR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Biodexa Pharmaceuticals plc American Depositary Shs

    6-K - Biodexa Pharmaceuticals Plc (0001643918) (Filer)

    3/18/26 5:11:41 PM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAP
    $AI
    $AMBA
    $ARDS
    Leadership Updates

    Live Leadership Updates

    View All

    Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

    Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses Research published in Nature Medicine highlighted promising results of multi-antigen targeted T cells in pancreatic cancer Strengthened manufacturing capabilities through collaboration with Cellipont Bioservices and expanded Board of Directors with appointment of Kathryn Penkus Corzo HOUSTON, March 18, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematological malignancies and solid tumors, today a

    3/18/26 5:31:30 PM ET
    $MRKR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wearable Devices Strengthens AI Advisory Board with Former Google and Qualcomm Executives to Accelerate ai6 Labs' Vision

    Yokneam Illit, Israel, March 16, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (NASDAQ:WLDS, WLDSW)) ("Wearable Devices" or the "Company"), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, today announced a significant expansion of its AI expert advisory board. This strategic enhancement strengthens the Company's commitment to advancing neural AI innovation through ai6 Labs. The recently launched ai6 Labs is focused on advancing the Company's revolutionary neural AI technology powered by non-invasive electromyography (EMG) technology and the Mudra platform, supporting a closed-loop ecosystem designed to seamlessly connect hu

    3/16/26 8:45:00 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results

    Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal trial (PiNACLE) evaluating ronde-cel is ongoingPhase 1 trial is ongoing for LYL273, an enhanced GCC-targeted CAR T-cell candidate for metastatic colorectal cancer; seven new patients treated without dose-limiting toxicity and including dose escalation to Dose Level 3Smital Shah was appointed Chief Financial and Business Officer in March 2026Second $50 million tranche of $100 million equity private placement closed in March 2026 after achievement of clinical milestone for ronde-celCash of approximate

    3/12/26 4:05:00 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAP
    $AI
    $AMBA
    $ARDS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Invivyd Inc.

    SC 13D/A - Invivyd, Inc. (0001832038) (Subject)

    12/12/24 4:39:09 PM ET
    $IVVD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAP
    $AI
    $AMBA
    $ARDS
    Financials

    Live finance-specific insights

    View All

    SEALSQ To Announce Full Year 2025 Audited Financial Results on March 31

    Geneva, Switzerland, March 18, 2026 (GLOBE NEWSWIRE) -- Conference Call to be Held on April 1 at 9:00am ET SEALSQ Corp (NASDAQ:LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, that it will release its audited financial results for the full year ("FY") ended December 31, 2025, after the close of the market on Tuesday, March 31, 2026. The Company will host a conference call to discuss these results on Wednesday, April 1, 2026 at 9:00 am ET (3:00 pm CET). If you wish to join the conference call, please use the dial-in information below: Toll-Free Dial-In Number: 877-445-9755Int

    3/18/26 4:45:00 PM ET
    $LAES
    Semiconductors
    Technology

    Sportsman's Warehouse Holdings, Inc. Schedules Fourth Quarter and Full-Year 2025 Earnings Conference Call

    WEST JORDAN, Utah, March 17, 2026 (GLOBE NEWSWIRE) -- Sportsman's Warehouse Holdings, Inc. ("Sportsman's Warehouse" or the "Company") (NASDAQ:SPWH) today announced that it will hold its quarterly conference call to discuss fourth quarter and full-year 2025 financial results on Tuesday, March 31, 2026, at 5:00 p.m. Eastern Time. A live audio webcast of the conference call will be available on the Company's investor relations website at http://investors.sportsmans.com/. A replay of the webcast will be available within two hours of the conclusion of the call through April 7, 2026, and can be accessed on the Company's investor relations website. About Sportsman's Warehouse Sportsman's Wareho

    3/17/26 4:10:00 PM ET
    $SPWH
    Other Specialty Stores
    Consumer Discretionary

    Horizon Technology Finance Corporation and Monroe Capital Corporation Announce Shareholder Approvals of Merger

    FARMINGTON, Conn. and CHICAGO, March 16, 2026 (GLOBE NEWSWIRE) -- Horizon Technology Finance Corporation (("HRZN", NASDAQ:HRZN) announced today that its shareholders, at a special meeting held on March 13, 2026, approved the issuance of HRZN's common stock (the "HRZN Share Issuance Proposal") in connection with the proposed merger of Monroe Capital Corporation (NASDAQ:MRCC) ("MRCC") with and into HRZN (the "Merger"). In addition, MRCC announced today that its shareholders, at a special meeting held on March 13, 2026, approved: (1) the proposed Merger and (2) the related proposed sale of substantially all of MRCC's assets to Monroe Capital Income Plus Corporation ("MCIP") at fair value for

    3/16/26 9:15:00 AM ET
    $HRZN
    $MRCC
    Finance: Consumer Services
    Finance
    Investment Managers